Cardiex is raising up to $6.5m via a $2.4m institutional placement and a $4.1m entitlement offer Funds will support the commercial expansion of CONNEQT Health, covering devices and digital arterial health solutions C2 Ventures has committed $1.94m and will sub-underwrite up to $1.2m of the entitlement shortfall, subject to approvals Health technology company Cardiex … Read more
ASX health stocks up 1.2% over past five days while the broader market is up 0.8% HealthCo REIT agrees to short-term partial rent deferral with troubled Healthscope and its receivers New-Zealand-based soft-tissue repair company Aroa Biosurgery delivers maiden full-year profit Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans … Read more
Ambitious empires always decline. They do so with a combination of over-spending… and overextending themselves militarily. Those risks, and their consequences, have been well known. ‘I had been imagining what war was like – everything on fire, children crying, cats running about, and when we got to Stalingrad it turned out to be really like … Read more
Compulsory superannuation’s climb to 12 per cent of wages will help deliver today’s young adults a super balance above $600,000, new research suggests. However, the July 1 rise – from 11.5 per cent currently – won’t guarantee a comfortable retirement for some workers, the Association of Superannuation Funds of Australia warns. An ASFA research note … Read more
There was a nasty drop in the ASX last year, attributed to the yen carry trade. That time, it was short, sharp, and quickly forgotten. But Japan—long ignored in share market chatter—might rumble markets again. Odds are, I suspect Nick is right.The question, as always, is timing. Three things I’m thinking about today… 1) This … Read more
It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations. Andrew Eddy – Morgans Financial BUY WiseTech Global (ASX:WTC) Wisetech is acquiring E2open, expanding its market reach and capabilities, driving revenue and EBITDA … Read more
In light of the recent uranium surge, James Cooper touches on the need to focus on markets with strong fundamental strength, and getting in before the mainstream tide washes in As an investor, should you wait for confirmation that a market is moving or invest before prices rise? It’s an important question. You’re either a … Read more
Financial adviser use only. Not for distribution to retail clients. The past 5-years was a period in which investors might expect active management to outperform, and Australian managers have been advertising just that. With heightened volatility and uncertainty during the Covid pandemic, the return of inflation and fastest RBA hiking cycle in history, the broad … Read more
